Back to Search
Start Over
A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic.
- Source :
-
Turkish Journal of Medical Sciences . 2021, Vol. 51 Issue 5, p2243-2247. 5p. - Publication Year :
- 2021
-
Abstract
- Background/aim: COVID-19 pandemic created concerns among patients receiving immunosuppressive therapy. Frequency of COVID-19 and impact of lockdown on treatment compliance in patients with vasculitis are largely unknown. Materials and method: Patients with ANCA-associated and large vessel vasculitis that have been followed-up in our clinic were contacted by phone and a questionnaire containing home isolation status, treatment adherence and history of COVID-19 between March 1st and June 30th, 2020 was applied. Results: The survey was applied to 103 patients (F/M: 59/44, mean age: 53.2±12.5). Thirty-three (32%) patients didn’t attend at least one appointment; 98(95.1%) noted that they spent 3 months in home isolation. Five patients (4.8%) received immunosuppressives irregularly and 3(2.9%) developed symptoms due to undertreatment. Four (3.9%) patients admitted to hospital with a suspicion of COVID-19, but none of them had positive PCR or suggestive findings by imaging. COVID-19 was diagnosed in a patient with granulomatosis with polyangiitis during hospitalization for disease flare and she died despite treatment. Conclusion: Frequency of COVID-19 was low in patients with vasculitis in our single center cohort. Although outpatient appointments were postponed in one-third of our patients, high compliance with treatment and isolation rules ensured patients with vasculitis overcome this period with minimal morbidity and mortality. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 13000144
- Volume :
- 51
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Turkish Journal of Medical Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 153254674
- Full Text :
- https://doi.org/10.3906/sag-2010-267